Publications

Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria.

White, NJ; Ashley, EA; Recht, J; DELVES, MJ; Ruecker, A; Smithuis, FM; Eziefula, AC; BOUSEMA, T; DRAKELEY, C; Chotivanich, K; Imwong, M; Pukrittayakamee, S; Prachumsri, J; Chu, C; Andolina, C; Bancone, G; Hien, TT; Mayxay, M; Taylor, WR J; Von Seidlein, L; Price, RN; Barnes, KI; Djimdé, A; Ter Kuile, F; GOSLING, R; ... Nosten, FH.

2014

Malaria journal, (2014).13 1 10.1186/1475-2875-13-483.

Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains.

Chugh, M; Scheurer, C; Sax, S; Bilsland, E; VAN SCHALKWYK, DA; Wicht, KJ; Hofmann, N; Sharma, A; Bashyam, S; Singh, S; Oliver, SG; Egan, TJ; Malhotra, P; SUTHERLAND, CJ; Beck, H-P; Wittlin, S; Spangenberg, T; Ding, XC;

2014

Antimicrobial agents and chemotherapy, (2014).59 2 10.1128/AAC.03265-14.

The mode of action of spatial repellents and their impact on vectorial capacity of Anopheles gambiae sensu stricto.

Ogoma, SB; Ngonyani, H; Simfukwe, ET; Mseka, A; MOORE, J; Maia, MF; Moore, SJ; LORENZ, LM;

2014

PloS one, (2014).9 12 10.1371/journal.pone.0110433.

In silico comparative genomics analysis of Plasmodium falciparum for the identification of putative essential genes and therapeutic candidates.

Rout, S; WARHURST, DC; Suar, M; Mahapatra, RK;

2014

Journal of microbiological methods, (2014).109, 10.1016/j.mimet.2014.11.016.

Plasmodium alveolins possess distinct but structurally and functionally related multi-repeat domains.

AL-KHATTAF, FS; TREMP, AZ; DESSENS, JT;

2014

Parasitology research, (2014).114 2 10.1007/s00436-014-4226-9.

Mass screening and treatment on the basis of results of a Plasmodium falciparum-specific rapid diagnostic test did not reduce malaria incidence in Zanzibar.

COOK, J; Xu, W; Msellem, M; Vonk, M; Bergström, B; GOSLING, R; Al-Mafazy, A-W; McElroy, P; Molteni, F; Abass, AK; Garimo, I; Ramsan, M; Ali, A; Mårtensson, A; Björkman, A;

2014

The Journal of infectious diseases, (2014).211 9 10.1093/infdis/jiu655.

Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis.

Okell, LC; CAIRNS, M; Griffin, JT; Ferguson, NM; Tarning, J; Jagoe, G; Hugo, P; Baker, M; D'ALESSANDRO, U; BOUSEMA, T; Ubben, D; Ghani, AC;

2014

Nature communications, (2014).5 1 10.1038/ncomms6606.

Comparison of routine health management information system versus enhanced inpatient malaria surveillance for estimating the burden of malaria among children admitted to four hospitals in Uganda.

Mpimbaza, A; Miles, M; Sserwanga, A; Kigozi, R; Wanzira, H; Rubahika, D; Nasr, S; Kapella, BK; Yoon, SS; Chang, M; Yeka, A; STAEDKE, SG; Kamya, MR; Dorsey, G;

2014

The American journal of tropical medicine and hygiene, (2014).92 1 10.4269/ajtmh.14-0284.

Serologically defined variations in malaria endemicity in Pará state, Brazil.

Cunha, MG; Silva, ES; Sepúlveda, N; Costa, SP T; Saboia, TC; Guerreiro, JF; Póvoa, MM; CORRAN, PH; RILEY, E; DRAKELEY, CJ;

2014

PloS one, (2014).9 11 10.1371/journal.pone.0113357.

Artemisinin resistance--modelling the potential human and economic costs.

Lubell, Y; Dondorp, A; Guérin, PJ; DRAKE, T; MEEK, S; Ashley, E; Day, NP J; White, NJ; White, LJ;

2014

Malaria journal, (2014).13 1 10.1186/1475-2875-13-452.